Dr. Middleman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
415 6th St
Lewiston, ID 83501Phone+1 208-743-2511Fax+1 208-799-5554- Is this information wrong?
Education & Training
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1969 - 1971
- UPMC Medical EducationResidency, Internal Medicine, 1968 - 1969
- UPMC Medical EducationInternship, Internal Medicine, 1965 - 1966
- University of Pittsburgh School of MedicineClass of 1965
Certifications & Licensure
- TN State Medical License 2023 - 2025
- TX State Medical License 1969 - 2024
- OH State Medical License 2018 - 2024
- WV State Medical License 2018 - 2023
- ID State Medical License 2011 - 2022
- AZ State Medical License 2017 - 2021
- WA State Medical License 2015 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsA randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.Adam Brufsky, Karen Hoelzer, Thaddeus Beck, Robert C. Whorf, Mark Keaton, Padma Nadella, Elisa Krill-Jackson, Joan Kroener, Edward Middleman, Michael Frontiera, Devcha...> ;Clinical Breast Cancer. 2011 Aug 1
- 57 citationsA Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung CancerThomas J. Lynch, David Fenton, Vera Hirsh, David Bodkin, Edward L. Middleman, Alberto Chiappori, Balazs Halmos, Reyna Favis, Hua Liu, William L. Trepicchio, Omar Eton,...> ;Journal of Thoracic Oncology. 2009 Aug 1
- 157 citationsRandomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–S...Charles A. Butts, David Bodkin, Edward L. Middleman, Craig W. Englund, David W. Ellison, Yasmin Alam, Harvey Kreisman, Peter Graze, James F. Maher, Helen J. Ross, Pete...> ;Journal of Clinical Oncology. 2007 Dec 20
- Join now to see all
Hospital Affiliations
- Methodist Charlton Medical CenterDallas, Texas
- Methodist Dallas Medical CenterDallas, Texas
- Methodist Mansfield Medical CenterMansfield, Texas
- University General Hospital-DallasDallas, Texas
- St. Joseph Regional Medical CenterLewiston, Idaho
- Davis Medical CenterElkins, West Virginia
- Southeastern Medical CenterCambridge, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: